Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-13

Clinical Trial Update: Efficacy and Safety of HRS-7535 Tablets in Obese Subjects . [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of HRS-7535 tablets in adults with obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Overweight and Obesity | Phase 2 | Status: COMPLETED